The effect of Heilichrysum pseudoplicatum-syrupe on clinical manifestations of patients with COVID-19

The effect of Heilichrysum pseudoplicatum-syrupe on clinical manifestations and Para clinical features in patients with COVID-19: A Randomized clinical trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180610040049N6

Enrollment

Registered

2020-12-04

Start date

2020-05-18

Completion date

Unknown

Last updated

2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Corona Virus. COVID-19, virus identified

Interventions

Intervention 1: "Intervention group:" This group consumes the Heilichrysum pseudoplicatum-syrupe. The concentration of this syrup is 10% of the aqueous extract of Heilichrysum pseudoplicatum-syrupe. T

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: Having informed consent to participate in the study The definitive diagnosis of COVID-19 Failure to attend another clinical trial simultaneously

Exclusion criteria

Exclusion criteria: Patient's willingness to use other therapies Alzheimer's patients

Design outcomes

Primary

Measure	Time frame
Fatigue. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a fatigue questionnaire.;Anorexia. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using anorexia questionnaire.;Oxygen saturation. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a pulse oximeter.;Blood pressure. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a sphygmomanometer.	—

Measure

Time frame

Fatigue. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a fatigue questionnaire.;Anorexia. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using anorexia questionnaire.;Oxygen saturation. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a pulse oximeter.;Blood pressure. Timepoint: One day before the intervention and 2 weeks after the intervention is measured. Method of measurement: Using a sphygmomanometer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHosein Sarmadian

Arak University of Medical Sciences

hosseinsarmadian2015@yahoo.com+98 86 3417 3601

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026